Gerardo Guillén

4.4k total citations
160 papers, 3.0k citations indexed

About

Gerardo Guillén is a scholar working on Infectious Diseases, Public Health, Environmental and Occupational Health and Epidemiology. According to data from OpenAlex, Gerardo Guillén has authored 160 papers receiving a total of 3.0k indexed citations (citations by other indexed papers that have themselves been cited), including 64 papers in Infectious Diseases, 57 papers in Public Health, Environmental and Occupational Health and 55 papers in Epidemiology. Recurrent topics in Gerardo Guillén's work include Mosquito-borne diseases and control (54 papers), Viral Infections and Vectors (39 papers) and Viral Infections and Outbreaks Research (30 papers). Gerardo Guillén is often cited by papers focused on Mosquito-borne diseases and control (54 papers), Viral Infections and Vectors (39 papers) and Viral Infections and Outbreaks Research (30 papers). Gerardo Guillén collaborates with scholars based in Cuba, Japan and Thailand. Gerardo Guillén's co-authors include Lisset Hermida, María G. Guzmán, Jorge Berlanga‐Acosta, Laura Lazo, Iris Valdés, Lázaro Gil, Lídice Bernardo, Ernesto Marcos, Yssel Mendoza‐Marí and Yaremis Romero and has published in prestigious journals such as The Lancet, SHILAP Revista de lepidopterología and The Journal of Immunology.

In The Last Decade

Gerardo Guillén

149 papers receiving 2.9k citations

Peers

Gerardo Guillén
Shigefumi Okamoto Japan
Virmondes Rodrigues Brazil
Sean A. Diehl United States
Pierre Corbeau France
Nathalie Dereuddre‐Bosquet France
Giulia Freer Italy
Norihisa Ishii Japan
Esther C. de Jong Netherlands
Anna L. Cogen United States
A H Fortier United States
Shigefumi Okamoto Japan
Gerardo Guillén
Citations per year, relative to Gerardo Guillén Gerardo Guillén (= 1×) peers Shigefumi Okamoto

Countries citing papers authored by Gerardo Guillén

Since Specialization
Citations

This map shows the geographic impact of Gerardo Guillén's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Gerardo Guillén with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Gerardo Guillén more than expected).

Fields of papers citing papers by Gerardo Guillén

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Gerardo Guillén. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Gerardo Guillén. The network helps show where Gerardo Guillén may publish in the future.

Co-authorship network of co-authors of Gerardo Guillén

This figure shows the co-authorship network connecting the top 25 collaborators of Gerardo Guillén. A scholar is included among the top collaborators of Gerardo Guillén based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Gerardo Guillén. Gerardo Guillén is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Lobaina, Yadira, Rong Chen, Edith Suzarte Portal, et al.. (2024). A Nasal Vaccine Candidate, Containing Three Antigenic Regions from SARS-CoV-2, to Induce a Broader Response. Vaccines. 12(6). 588–588. 4 indexed citations
2.
Berlanga‐Acosta, Jorge, Ariana García‐Ojalvo, José I Fernández‐Montequín, et al.. (2024). Epidermal Growth Factor Intralesional Delivery in Chronic Wounds: The Pioneer and Standalone Technique for Reversing Wound Chronicity and Promoting Sustainable Healing. International Journal of Molecular Sciences. 25(20). 10883–10883. 4 indexed citations
3.
Villafranca, Roberto Cañete, et al.. (2024). Pharmacodynamic of Recombinant Human Interferon Alpha-2b Nasal Drops and Effective Prophylaxis Against SARS-COV-2 Infection. Journal of Interferon & Cytokine Research. 44(6). 271–280. 1 indexed citations
4.
Yoshida, Osamu, Yusuke Imai, Sheikh Mohammad Fazle Akbar, et al.. (2023). Intranasal HBsAg/HBcAg-Containing Vaccine Induces Neutralizing Anti-HBs Production in Hepatitis B Vaccine Non-Responders. Vaccines. 11(9). 1479–1479. 4 indexed citations
5.
Lobaina, Yadira, Rong Chen, Edith Suzarte Portal, et al.. (2023). Broad humoral immunity generated in mice by a formulation composed of two antigens from the Delta variant of SARS-CoV-2. Archives of Virology. 168(7). 190–190. 1 indexed citations
6.
Al‐Mahtab, Mamun, Sheikh Mohammad Fazle Akbar, Osamu Yoshida, et al.. (2023). Antiviral Response across Genotypes after Treatment of Chronic Hepatitis B Patients with the Therapeutic Vaccine NASVAC or Pegylated Interferon. Vaccines. 11(5). 962–962. 2 indexed citations
7.
Yoshida, Osamu, Sheikh Mohammad Fazle Akbar, Yusuke Imai, et al.. (2022). Intranasal therapeutic vaccine containing HBsAg and HBcAg for patients with chronic hepatitis B; 18 months follow‐up results of phase IIa clinical study. Hepatology Research. 53(3). 196–207. 14 indexed citations
8.
Akbar, Sheikh Mohammad Fazle, Mamun Al Mahtab, Sakirul Khan, et al.. (2022). Innovative Therapies Targeting the Virus and the Host for Treating Chronic Hepatitis B Virus Infection: From Bench to Bedside. Vaccines. 10(5). 746–746. 1 indexed citations
9.
Fernández, Julio R., et al.. (2021). Comparison between nasopharyngeal swabs and saliva as reliable specimens for the diagnosis of SARS-CoV-2. SHILAP Revista de lepidopterología.
10.
Akbar, Sheikh Mohammad Fazle, Mamun Al Mahtab, Julio Aguilar, et al.. (2021). Sustained Antiviral and Liver Protection by a Nasal Therapeutic Vaccine (NASVAC, Containing Both HBsAg and HBcAg) in Patients with Chronic Hepatitis B: 2-Year Follow-Up of Phase III Clinical Trial. Pathogens. 10(11). 1440–1440. 18 indexed citations
11.
12.
Mendoza‐Marí, Yssel, et al.. (2017). GHRP-6, a novel candidate for prevention and treatment of fibrotic disorders. SHILAP Revista de lepidopterología.
13.
Lobaina, Yadira, Jorge Aguiar, Eduardo Pentón, et al.. (2015). Demostración de la seguridad, inmunogenicidad y evidencias de la eficacia del candidato vacunal HeberNasvac y caracterización de las poblaciones de pacientes con hepatitis B crónica. Biotecnología aplicada. 32(3). 3511–3513. 1 indexed citations
14.
Pimentel, Eulogio, et al.. (2014). Effect of a GnRH vaccine formulation on testosterone concentrations and reproduction in adult male rats. SHILAP Revista de lepidopterología. 2 indexed citations
15.
Guillén, Isabel, María Elena Ochagavia, Julio R. Fernández, et al.. (2012). Effect of human epidermal growth factor on the tumor cell line A431: in vivo analysis of tumor growth inhibition and gene expression. SHILAP Revista de lepidopterología. 29(3). 155–161. 2 indexed citations
16.
Gil, Jeovanis, Lázaro Betancourt, Daniel Yero, et al.. (2009). Proteomic study via a non-gel based approach of meningococcal outer membrane vesicle vaccine obtained from strain CU385: A road map for discovering new antigens. Human Vaccines. 5(5). 347–356. 20 indexed citations
17.
Yero, Daniel, Yanet Climent, Lázaro Betancourt, et al.. (2009). Analysis of the genetic variability and immunological properties of the NlpB antigen, a novel protein identified in Neisseria meningitidis. SHILAP Revista de lepidopterología. 26(1). 84–87.
18.
Cibrián, Danay, et al.. (2008). Efecto citoprotector cardíaco y extracardíaco del péptido GHRP6. Biotecnología aplicada. 25(3). 276–278. 3 indexed citations
19.
Lobaina, Yadira, Enrique V. Iglesias, Verena Muzio, et al.. (2008). Comparison of the immune response induced in mice by five commercial vaccines based on recombinant HBsAg from different sources, implications on their therapeutic use. Biotecnología aplicada. 25(4). 325–331. 1 indexed citations
20.
Cabrales, Ania, et al.. (2008). Identification of an interleukin-15 antagonist peptide. Biotecnología aplicada. 25(4). 320–324. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Shigefumi Okamoto Breakdown of academic impact, for papers by Virmondes Rodrigues Breakdown of academic impact, for papers by Sean A. Diehl Breakdown of academic impact, for papers by Pierre Corbeau Breakdown of academic impact, for papers by Nathalie Dereuddre‐Bosquet Breakdown of academic impact, for papers by Giulia Freer Breakdown of academic impact, for papers by Norihisa Ishii Breakdown of academic impact, for papers by Esther C. de Jong Breakdown of academic impact, for papers by Anna L. Cogen Breakdown of academic impact, for papers by A H Fortier
Rankless by CCL
2026